Woodline Partners’s Elanco Animal Health ELAN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $45.5M | Buy |
+3,189,185
| New | +$45.5M | 0.24% | 114 |
|
|
2024
Q3 | – | Sell |
-594,979
| Closed | -$8.59M | – | 627 |
|
|
2024
Q2 | $8.59M | Buy |
+594,979
| New | +$8.59M | 0.08% | 268 |
|
|
2024
Q1 | – | Sell |
-1,227,165
| Closed | -$18.3M | – | 561 |
|
|
2023
Q4 | $18.3M | Sell |
1,227,165
-2,612,962
| -68% | -$38.9M | 0.2% | 152 |
|
|
2023
Q3 | $43.2M | Buy |
3,840,127
+3,130,273
| +441% | +$35.2M | 0.51% | 42 |
|
|
2023
Q2 | $7.14M | Buy |
+709,854
| New | +$7.14M | 0.08% | 248 |
|
|
2021
Q3 | – | Sell |
-136,322
| Closed | -$4.73M | – | 700 |
|
|
2021
Q2 | $4.73M | Buy |
+136,322
| New | +$4.73M | 0.09% | 228 |
|
|
2021
Q1 | – | Sell |
-383,325
| Closed | -$11.8M | – | 441 |
|
|
2020
Q4 | $11.8M | Buy |
+383,325
| New | +$11.8M | 0.31% | 97 |
|